Harnessing next-generation sequencing (NGS), Polaris Genomics™ brings biological clarity and objectivity to the assessment, diagnosis, and treatment of mental health conditions. Our core research tool, the ADAPT Panel™ curates information on 1000+ transcriptomic biomarkers related to known system pathways in neuropsychiatric conditions. The ADAPT Panel™ is the only panel designed specifically for researchers focused on identifying novel targets and measuring changes in targets for the advancement of novel therapies and precision treatment for mental and brain health conditions.